You have 9 free searches left this month | for more free features.

vi-0521

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Blood Pressure Trial in United States (VI-0521, Phentermine, Placebo)

Recruiting
  • Blood Pressure
  • VI-0521
  • +2 more
  • Mobile, Alabama
  • +19 more
Aug 15, 2022

Obesity Trial in Durham, Philadelphia (VI-0521, topiramate, phentermine)

Completed
  • Obesity
  • VI-0521
  • +2 more
  • Durham, North Carolina
  • +1 more
Mar 10, 2015

Overweight, Obesity Trial in Lincoln (VI-0521, Placebo, Alcohol)

Completed
  • Overweight
  • Obesity
  • VI-0521
  • +3 more
  • Lincoln, Nebraska
    Research Site
Aug 1, 2013

Sleep Apnea Trial in Louisville (VI-0521, )

Completed
  • Sleep Apnea
  • VI-0521
  • placebo
  • Louisville, Kentucky
    Kentucky Research Group
Sep 5, 2012

Obesity Trial in United States (VI-0521, Placebo matched phentermine/topiramate)

Completed
  • Obesity
  • VI-0521
  • Placebo matched phentermine/topiramate
  • San Diego, California
  • +4 more
Sep 5, 2012

Obesity Trial (VI-0521, Placebo)

Completed
  • Obesity
  • VI-0521
  • Placebo
  • (no location specified)
Sep 5, 2012

Obesity, Type 2 Diabetes Trial in United States (VI-0521)

Completed
  • Obesity
  • Type 2 Diabetes
  • VI-0521
  • Birmingham, Alabama
  • +5 more
Sep 5, 2012

Diabetes Trial in United States (VI-0521)

Terminated
  • Diabetes
  • VI-0521
  • Birmingham, Alabama
  • +8 more
Sep 5, 2012

Type 2 Diabetes Trial in United States (VI-0521, Placebo)

Completed
  • Type 2 Diabetes Mellitus
  • VI-0521
  • Placebo
  • Birmingham, Alabama
  • +8 more
Sep 5, 2012

Torsades de Pointes Trial in Phoenix (VI-0521)

Completed
  • Torsades de Pointes
  • VI-0521
  • Phoenix, Arizona
    MDS Pharma Services
Jan 20, 2010